Studio City International Holdings Limited Announces Filing of Annual Report on Form 20-F for Fiscal Year 2020
March 31, 2021 07:51 ET
|
Studio City
MACAU, March 31, 2021 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Bone Therapeutics nomme le Dr. Anthony Ting, un expert de l’industrie de la thérapie cellulaire, en qualité de Directeur Scientifique
March 30, 2021 01:00 ET
|
Bone Therapeutics SA
Gosselies, Belgique, le 30 mars 2021, 7h00 CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris: BOTHE), société de thérapie cellulaire répondant aux besoins médicaux non satisfaits en orthopédie...
Bone Therapeutics appoints industry cell therapy expert, Anthony Ting, PhD as Chief Scientific Officer
March 30, 2021 01:00 ET
|
Bone Therapeutics SA
Gosselies, Belgium, 30 March 2021, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases,...
Studio City International Holdings Limited Announces Unaudited Fourth Quarter 2020 Earnings
February 25, 2021 08:10 ET
|
Studio City
MACAU, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Studio City Announces Earnings Release Date
February 18, 2021 06:42 ET
|
Studio City
MACAU, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC), a world-class integrated resort located in Cotai, Macau, today announces that it will furnish its...
Update to 01/26/21 COVI-MSC™ Press Release: Fourth Patient Also Released From Hospital Following Third Infusion of Stem Cells
January 31, 2021 17:28 ET
|
Sorrento Therapeutics, Inc.
Fourth patient, who spent more than two weeks in hospital and needed invasive mechanical ventilation, was treated with COVI-MSC starting Monday (January 25, 2021) and discharged last Friday (January...
Bone Therapeutics et Rigenerand signent un partenariat pour le développement d’un processus de thérapie cellulaire
January 14, 2021 01:00 ET
|
Bone Therapeutics SA
Gosselies, Belgique et Modène, Italie, le 14 janvier 2021, 7h00 CET – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de...
Bone Therapeutics and Rigenerand sign partnership for cell therapy process development
January 14, 2021 01:00 ET
|
Bone Therapeutics SA
Gosselies, Belgium and Modena, Italy, 14 January 2021, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and...
Bone Therapeutics traite le premier patient de l’étude de Phase IIb évaluant ALLOB dans les fractures du tibia
January 12, 2021 01:00 ET
|
Bone Therapeutics SA
INFORMATION REGLEMENTEE Fin du recrutement des patients attendue au premier semestre 2022 Résultats principaux de l’étude attendus au second semestre 2022 Gosselies, Belgique, 12...
Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study
January 12, 2021 01:00 ET
|
Bone Therapeutics SA
REGULATED INFORMATION All patients expected to be recruited in H1 2022 Topline results anticipated in H2 2022 Gosselies, Belgium, 12 January 2020, 7am CEST – BONE...